HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.

Abstract
The point mutations in the Plasmodium falciparum dihydrofolate reductase (dhfr) and the dihydropteroate synthase (dhps) genes that are linked to sulphadoxine-pyrimethamine (SP) resistance in vitro have been well characterised. To determine whether a few of these mutations could predict SP treatment failure in vivo, two mutations (Asn-108 and Arg-59) in the dhfr gene and one (Glu-540) in the dhps gene were analysed according to the risk of SP parasitological failure (RI-RIII) at day 28 in pre-treatment isolates in 79 Ugandan children aged 6-59 (mean = 18.4, S.D. = 8.8) months with uncomplicated falciparum malaria. Neither the dhfr-108 (P = 0.3) nor the dhps-540 (P = 0.6) or dhfr-108 + dhps-540 (P = 0.04) mutations were significantly associated with SP parasitological failure. However, the dhfr-108 + dhfr-59 (P = 0.04), the dhfr-59 + dhps-540 (P = 0.04) and the dhfr-108 + dhfr-59 + dhps-540 (P = 0.02) mutations significantly increased the risk for SP parasitological failure. Our findings confirm an earlier report that the dhfr-59 and the dhps-540 mutations could be useful genetic markers for rapid screening of populations at high risk of SP resistance.
AuthorsAmbrose O Talisuna, Anne Nalunkuma-Kazibwe, Peter Langi, Theonest K Mutabingwa, William W Watkins, Eric Van Marck, Thomas G Egwang, Umberto D'Alessandro
JournalInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases (Infect Genet Evol) Vol. 4 Issue 4 Pg. 321-7 (Dec 2004) ISSN: 1567-1348 [Print] Netherlands
PMID15374529 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimalarials
  • Drug Combinations
  • Sulfadoxine
  • Tetrahydrofolate Dehydrogenase
  • Dihydropteroate Synthase
  • Pyrimethamine
Topics
  • Animals
  • Antimalarials (adverse effects, therapeutic use)
  • Child, Preschool
  • Dihydropteroate Synthase (genetics)
  • Drug Combinations
  • Drug Resistance
  • Follow-Up Studies
  • Humans
  • Infant
  • Malaria, Falciparum (drug therapy)
  • Plasmodium falciparum (enzymology, genetics)
  • Point Mutation
  • Pyrimethamine (adverse effects, therapeutic use)
  • Retrospective Studies
  • Sulfadoxine (adverse effects, therapeutic use)
  • Tetrahydrofolate Dehydrogenase (genetics)
  • Time Factors
  • Treatment Failure
  • Uganda (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: